New Summer Hours: Mondays 8:30-4:30 

Tuesdays & Fridays 8:30-12:00 Noon 

Wednesdays & Thursdays 8:30-3:00 


    Register and wait for approval


    for exclusive client discounts!!

Price: $59.95


    Blisphora™ is a revolutionary formula featuring clinically effective levels of SAMe (s-adenosyl-L-methionine), a compound native to the body that is a critical component of many biochemical reactions and plays an important role in supporting positive emotions. This powerful formula combines significant levels of body-ready folate (the next generation of folate with improved bioavailability ) and vitamin B12 (as easy-to-absorb methylcobalamin) to support SAMe metabolism , methylation, and healthy neurotransmitter synthesis for a balanced mood. Foil-wrapped, enteric-coated tablets ensure product stability.*

    • Scientifically designed to support a healthy mood and methylation*
    • Features clinically effective levels of SAMe and body-ready folate and vitamin B12 

    Serving Size: 1 Tablet 

    Ingredient   Amount   Daily Value 

    Folate [from (6S)-5-methyltetrahydrofolic acid, glucosamine salt†]  1 mg 250% 

    Vitamin B12,/sub> (as methylcobalamin)1 mg 16,667%

    S-Adenosyl-L-Methionine (SAMe) (as SAMe disulfate p-toluensulfonate)  400 mg* 

    Other Ingredients: Microcrystalline cellulose, magnesium stearate (vegetable), stearic acid (vegetable), silica, mannitol, carboxymethylstarch sodium salt, and coating (methacrylic acid copolymer, triethyl citrate, titanium dioxide, and silica).

    Directions: Take one tablet daily 30 minutes before a meal on an empty stomach with water or as directed by your healthcare practitioner. 

    This product is Gluten Free and Vegetarian. 

    Warning: Do not use if pregnant or nursing. 

    Caution: If you have a history of psychiatric disorders or if you are taking medications, please consult your healthcare practitioner prior to use. Keep out of the reach of children. 

    Storage: Keep in a cool, dry place. 

    †Quatrefolic® is a registered trademark of Gnosis S.P.A., U.S. Patent No.7,947,662.